José Rubio

1.5k total citations
38 papers, 1.0k citations indexed

About

José Rubio is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, José Rubio has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in José Rubio's work include Bladder and Urothelial Cancer Treatments (13 papers), Renal cell carcinoma treatment (8 papers) and Urinary and Genital Oncology Studies (8 papers). José Rubio is often cited by papers focused on Bladder and Urothelial Cancer Treatments (13 papers), Renal cell carcinoma treatment (8 papers) and Urinary and Genital Oncology Studies (8 papers). José Rubio collaborates with scholars based in Spain, United States and Austria. José Rubio's co-authors include E. Solsona, I. Iborra, J.V. Ricós, J. Casanova, Sergio Almenar, C Calabuig, JoAnn Trial, José A. Martínez-Climent, Antonio Llombart‐Bosch and David Ramos and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

José Rubio

37 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Rubio Spain 17 631 271 258 144 140 38 1.0k
Alain Le Duc France 21 354 0.6× 299 1.1× 672 2.6× 189 1.3× 122 0.9× 42 1.3k
Roger Li United States 22 898 1.4× 303 1.1× 578 2.2× 284 2.0× 176 1.3× 173 1.6k
Theresa Perrone United States 21 620 1.0× 77 0.3× 340 1.3× 206 1.4× 172 1.2× 32 1.4k
Rolf‐Peter Henke Germany 18 241 0.4× 69 0.3× 800 3.1× 96 0.7× 347 2.5× 48 1.1k
C. A. Makin United Kingdom 13 317 0.5× 62 0.2× 138 0.5× 195 1.4× 65 0.5× 24 972
David C. Wei United States 14 234 0.4× 264 1.0× 363 1.4× 221 1.5× 248 1.8× 19 879
Azael Freites‐Martínez Spain 14 181 0.3× 197 0.7× 259 1.0× 111 0.8× 37 0.3× 47 1.2k
Shalin Shah United States 13 324 0.5× 51 0.2× 242 0.9× 187 1.3× 16 0.1× 53 1.1k
R Bouvier France 14 156 0.2× 43 0.2× 192 0.7× 116 0.8× 38 0.3× 43 612
Richard Terrill United States 20 343 0.5× 27 0.1× 355 1.4× 89 0.6× 34 0.2× 30 900

Countries citing papers authored by José Rubio

Since Specialization
Citations

This map shows the geographic impact of José Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Rubio more than expected).

Fields of papers citing papers by José Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Rubio. The network helps show where José Rubio may publish in the future.

Co-authorship network of co-authors of José Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of José Rubio. A scholar is included among the top collaborators of José Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Rubio. José Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chopra, Supriya, May Abdel–Wahab, Sadhana Kannan, et al.. (2022). Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis. Radiotherapy and Oncology. 170. 70–78. 13 indexed citations
2.
Abdel–Wahab, May, Soehartati Gondhowiardjo, Arthur Accioly Rosa, et al.. (2021). Global Radiotherapy: Current Status and Future Directions—White Paper. JCO Global Oncology. 7(7). 827–842. 63 indexed citations
3.
Abdel–Wahab, May, Surbhi Grover, Eduardo Zubizarreta, & José Rubio. (2020). Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives. Brachytherapy. 19(6). 850–856. 12 indexed citations
4.
Marenco, José Luis, et al.. (2020). Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores. European Urology Focus. 7(6). 1254–1259. 21 indexed citations
5.
Alcaraz, Antonio, Luis Martínez‐Piñeiro, José Rubio, et al.. (2017). [Consensus on castration-resistant prostate cancer management in Spain.]. PubMed. 70(9). 777–791. 4 indexed citations
6.
Izquierdo, Laura, Mercedes Ingelmo‐Torres, Carme Mallofré, et al.. (2017). Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study. Oncotarget. 8(31). 51522–51529. 9 indexed citations
7.
Bartoň, Michael, Eduardo Zubizarreta, & José Rubio. (2017). Radiotherapy in small countries. Cancer Epidemiology. 50(Pt B). 257–259. 6 indexed citations
8.
Izquierdo, Laura, Lluís Peri, Antonio Alcaraz, et al.. (2015). The role of cystectomy in elderly patients – a multicentre analysis. British Journal of Urology. 116(S3). 73–79. 39 indexed citations
9.
Muro, Xavier García del, Enrique Gallardo, Iciar Garcı́a Carbonero, et al.. (2014). Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma. Cancer Chemotherapy and Pharmacology. 73(6). 1095–1107.
10.
Rossen, Roger D., José Rubio, JoAnn Trial, et al.. (2009). Monocyte CD49e and 110–120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell counts. AIDS. 23(17). 2247–2253. 2 indexed citations
11.
Ramos, David, Martı́n C. Abba, José Antonio López‐Guerrero, et al.. (2008). Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours. Histopathology. 52(7). 831–839. 33 indexed citations
12.
Ramos, David, Silvia Calabuig‐Fariñas, José Antonio López‐Guerrero, et al.. (2006). Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder. European Urology. 50(3). 506–515. 66 indexed citations
13.
Rubio, José, David Ramos, José Antonio López‐Guerrero, et al.. (2005). Immunohistochemical Expression of Ki-67 Antigen, Cox-2 and Bax/Bcl-2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy Specimens. European Urology. 48(5). 745–751. 79 indexed citations
14.
15.
Birdsall, Holly H., et al.. (2004). Impact of Fibronectin Fragments on the Transendothelial Migration of HIV-Infected Leukocytes and the Development of Subendothelial Foci of Infectious Leukocytes. The Journal of Immunology. 173(4). 2746–2754. 23 indexed citations
16.
Trial, JoAnn, José Rubio, Holly H. Birdsall, Maria C. Rodriguez‐Barradas, & Roger D. Rossen. (2004). Monocyte Activation by Circulating Fibronectin Fragments in HIV-1-Infected Patients. The Journal of Immunology. 173(3). 2190–2198. 16 indexed citations
17.
Solsona, Eduardo, et al.. (2004). The optimum timing of radical cystectomy for patients with recurrent high‐risk superficial bladder tumour. British Journal of Urology. 94(9). 1258–1262. 34 indexed citations
18.
Solsona, E., I. Iborra, José Rubio, et al.. (2003). Late Oncological Occurrences Following Radical Cystectomy in Patients with Bladder Cancer. European Urology. 43(5). 489–494. 54 indexed citations
19.
Wanahita, Anna, Daniel M. Musher, Jill E. Clarridge, et al.. (2002). Interaction between Human Polymorphonuclear Leukocytes and Streptococcus milleri Group Bacteria. The Journal of Infectious Diseases. 185(1). 85–90. 34 indexed citations
20.
Mario, Francesco Di, M. Cassaro, Raffaele Baffa, et al.. (1993). Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non‐ulcerous patients: is the bacterium a promoter of intestinal metaplasia?. Histopathology. 22(1). 9–16. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Le Duc Breakdown of academic impact, for papers by Roger Li Breakdown of academic impact, for papers by Theresa Perrone Breakdown of academic impact, for papers by Rolf‐Peter Henke Breakdown of academic impact, for papers by C. A. Makin Breakdown of academic impact, for papers by David C. Wei Breakdown of academic impact, for papers by Azael Freites‐Martínez Breakdown of academic impact, for papers by Shalin Shah Breakdown of academic impact, for papers by R Bouvier Breakdown of academic impact, for papers by Richard Terrill
Rankless by CCL
2026